Floatz logo

Exenatide

Diabetes Complications

University of California, Davisprotein_peptidePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Diabetes Complications cohort.

Asset / SponsorPhaseRating
Omnipaque
University of Colorado, Denver
Phase 1/2CCC
SODIUM P-AMINOHIPPURATE
University of Colorado, Denver
Phase 1/2CCC
Primepro™/ Primemsk™
Thomas Advanced Medical LLC
Phase 1/2CCC
Gfb-024
Goldfinch Bio, Inc.
Phase 1CC

Same molecule, other indications

Exenatide is also rated in:

type 2 diabetes mellitusDormant
BBB
Indicative ·
78 / 100
View asset →
prediabetes syndromeDormant
BBB
Indicative ·
76 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →